Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.

van Dijk WD, Heijdra Y, Lenders JW, Klerx W, Akkermans R, van der Pouw A, van Weel C, Scheepers PT, Schermer TR.

Respir Med. 2013 Jan;107(1):112-9. doi: 10.1016/j.rmed.2012.09.019. Epub 2012 Oct 12.

2.

A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.

van Dijk WD, Scheepers PT, Cremers R, Lenders JW, Klerx W, van Weel C, Schermer TR, Heijdra Y.

Trials. 2011 Feb 10;12:37. doi: 10.1186/1745-6215-12-37.

3.

Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.

van Dijk WD, Heijdra Y, Scheepers PT, Lenders JW, van Weel C, Schermer TR.

Med Hypotheses. 2010 Feb;74(2):277-80. doi: 10.1016/j.mehy.2009.09.012. Epub 2009 Oct 1.

PMID:
19800175
4.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

5.

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11.

PMID:
22789766
6.

Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.

Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.

Clin Ther. 2011 Dec;33(12):1974-84. doi: 10.1016/j.clinthera.2011.11.009.

PMID:
22177371
7.
9.

Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.

Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V.

Respir Med. 2012 Jan;106(1):84-90. doi: 10.1016/j.rmed.2011.09.006. Epub 2011 Oct 27.

10.

QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.

van Noord JA, Buhl R, Laforce C, Martin C, Jones F, Dolker M, Overend T.

Thorax. 2010 Dec;65(12):1086-91. doi: 10.1136/thx.2010.139113. Epub 2010 Oct 26.

PMID:
20978028
11.

Indacaterol therapy in patients with COPD not receiving other maintenance treatment.

Decramer M, Rossi A, Lawrence D, McBryan D.

Respir Med. 2012 Dec;106(12):1706-14. doi: 10.1016/j.rmed.2012.08.022. Epub 2012 Sep 29. Review. Erratum in: Respir Med. 2013 Jan;107(1):160. Dosage error in article text.

12.

A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.

Vogelmeier C, Aquino TO, O'Brien CD, Perrett J, Gunawardena KA.

COPD. 2012 Apr;9(2):111-20. doi: 10.3109/15412555.2011.641803.

PMID:
22458939
13.

Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II. Results of a randomised controlled trial.

Withey CH, Papacosta AO, Swan AV, Fitzsimons BA, Ellard GA, Burney PG, Colley JR, Holland WW.

J Epidemiol Community Health. 1992 Jun;46(3):281-5.

14.

Endurance shuttle walking test: responsiveness to salmeterol in COPD.

Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F.

Eur Respir J. 2008 Mar;31(3):579-84. Epub 2007 Dec 5.

15.

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.

Cazzola M, Segreti A, Stirpe E, Puxeddu E, Ora J, Rogliani P, Matera MG.

Respir Med. 2013 Jan;107(1):107-11. doi: 10.1016/j.rmed.2012.09.022. Epub 2012 Oct 18.

16.
17.

Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.

Berton DC, Barbosa PB, Takara LS, Chiappa GR, Siqueira AC, Bravo DM, Ferreira LF, Neder JA.

Thorax. 2010 Jul;65(7):588-93. doi: 10.1136/thx.2009.120857.

PMID:
20627914
18.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.

19.

Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.

Porto EF, Castro AA, Nascimento O, Oliveira RC, Cardoso F, Jardim JR.

Respir Med. 2009 Feb;103(2):251-7. doi: 10.1016/j.rmed.2008.08.018. Epub 2008 Oct 19.

20.

Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.

Taube C, Kanniess F, Grönke L, Richter K, Mücke M, Paasch K, Eichler G, Jörres RA, Magnussen H.

Respir Med. 2003 May;97(5):568-77.

PMID:
12735677
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk